1. 352Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations. (28th August 2018) Authors: Hopkins, P N; Krempf, M; Bruckert, E; Luc, G; Donahue, S; Yang, F; Zhang, Y; Dicioccio, A T Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer. Issue 7 (4th April 2016) Authors: Bekkar, S; Gronnier, C; Renaud, F; Duhamel, A; Pasquer, A; Théreaux, J; Gagnière, J; Meunier, B; Collet, D; Mariette, C; Dhahri, A; Lignier, D; Cossé, C; Regimbeau, J-M; Luc, G; Cabau, M; Jougon, J; Badic, B; Lozach, P; Bail, J P Journal: British journal of surgery Issue: Volume 103:Issue 7(2016) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗